Healthcare News and Research

Latest Healthcare News and Research

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced that the U.S. Food and Drug Administration approved LONSURF (trifluridine and tipiracil), formerly known as TAS-102, for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy.

22 Sep 2015

Medgen completes acquisition of Alternaturals

Medgen, Inc. today announced that it has completed the acquisition of Alternaturals, the operating subsidiary of Alternaturals, Inc., and a popular alternative healthcare and natural remedies company. The acquisition was made in an effort to increase the company's consumer reach and revenue base, and could be the most exciting event in several years, positioning the company to take some major steps forward.

22 Sep 2015

Stanford Hospital starts key study on pressure ulcer prevention

Leaf Healthcare is pleased to announce that a key study on pressure ulcer prevention has started at Stanford Hospital.

22 Sep 2015

$Bisphosphonate drugs linked to greater risk of atypical hip fractures$

Bisphosphonate drugs linked to greater risk of atypical hip fractures

The use of bisphosphonates, a group of drugs used to prevent hip breakages in women with osteoporosis, is associated with an increased risk of atypical fractures in this joint, understood as those that occur in less frequent locations.

22 Sep 2015

FDA approves Impax Laboratories' generic version of Testred Capsules 10 mg

Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration has approved its generic version of Testred Capsules 10 mg.

22 Sep 2015

UIC to develop and test outreach program to improve children’s oral health in Chicago

The University of Illinois at Chicago will develop and test an outreach program to reduce cavities in Chicago's low-income and minority infants and toddlers under a five-year, $5 million grant from the National Institutes of Health.

22 Sep 2015

AmpliPhi's novel bacteriophage therapy demonstrates comparable efficacy to vancomycin in S. aureus lung infection model

AmpliPhi Biosciences Corporation, a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, today announced experimental results highlighting that its prototype bacteriophage cocktail demonstrated comparable efficacy to vancomycin in reduction of Staphylococcus aureus in a murine lung infection model.

22 Sep 2015

Survey: Only half of primary care physicians aware of Complete Emollient Therapy for managing patients with eczema

The results of a new survey have found that only half of primary care practitioners are aware of Complete Emollient Therapy as a principle for managing patients with dry skin/eczema.

22 Sep 2015

New Medicare payment model reduces use of low-value services

In the first large-scale study to assess the effects of the Affordable Care Act's reforms to physician and hospital payments on the use of wasteful health care services, researchers have found that a new Medicare payment model reduced the number of times patients received services providing little or no health benefit.

22 Sep 2015

New study calls for new treatments for carbapenem-resistant Enterobacteriaceae infection

Researchers at The Medicines Company presented data from a multi-national cohort that demonstrates the mortality and morbidity, and poor outcomes, associated with current therapies in patients with infections due to carbapenem-resistant Enterobacteriaceae (CRE). The data from this analysis has guided the design of the company’s on-going clinical studies of its Phase 3 compound, CARBAVANCE® (meropenem/RPX7009) and was presented at the Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and the International Congress of Chemotherapy and Infection (ICC) joint meeting in San Diego, CA.

22 Sep 2015

BWH, DFCI researchers receive $10 million to test effectiveness of aspirin in women with breast cancer

Researchers from Brigham and Women's Hospital and Dana-Farber Cancer Institute have received a $10 million Breakthrough Award from the Department of Defense's Office of the Congressionally Directed Medical Research Program to test whether aspirin helps women with breast cancer avoid recurrence and live longer.

22 Sep 2015

Study compares effectiveness of nafcillin and cefazolin in patients with MSSA blood stream infections

Research comparing clinical outcomes between patients receiving nafcillin and cefazolin for treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia shows that overall treatment failure rate among patients receiving cefazolin was no worse than nafcillin, and significantly fewer adverse effects were documented for those receiving cefazolin.

22 Sep 2015

Prime Healthcare Services agrees to acquire Lehigh Regional Medical Center

Prime Healthcare Services has signed a definitive agreement to acquire the 88-bed Lehigh Regional Medical Center located in Lehigh Acres, Florida and related businesses, including physician clinic operations and ancillary services from subsidiaries of Community Health Systems.

21 Sep 2015

PDL BioPharma purchases portion of royalties on expected sales of AcelRx's Zalviso

PDL BioPharma, Inc. announced today that it has acquired a portion of the royalties on expected sales of AcelRx Pharmaceuticals Inc.'s Zalviso (sufentanil sublingual tablet system) in the European Union, Switzerland and Australia by its commercial partner, Grunenthal.

21 Sep 2015

Mölnlycke Health Care selects Mindtree to improve SAP application management

Mindtree, a leading digital transformation and technology services company, today announced that it has been selected by Mölnlycke Health Care, a world-leading provider of single-use surgical and wound care solutions, to enhance business efficiency using the SAP application suite. This will help Mölnlycke Health Care optimize the time to market of its products.

21 Sep 2015

Invitae launches new education program to increase awareness of genetic testing for hereditary cancer

A new survey released today shows 73 percent of Americans are aware of genetic testing for hereditary cancers – a significant increase over just a few years ago. Previous research found that in 2010 less than half of the Americans surveyed said they were aware of genetic testing. Dubbed the "Angelina Jolie Effect," the current data highlight the far-reaching impact of Angelina Jolie's public discussion of genetic testing for hereditary cancer.

21 Sep 2015

Evidera releases new software platform to support real-time analysis of healthcare data

Evidera, a leading provider of evidence-based solutions for the healthcare industry, is pleased to announce Evalytica, a new software platform designed to support near real-time analyses of virtually any type of real-world data source, including claims, electronic medical records, and registry data.

21 Sep 2015

Promising new innovations in drug development, health monitoring may improve drug safety in the future

Adverse drug reactions are harmful to patients and a major burden for healthcare providers, governments and the pharmaceutical industry. But promising new breakthroughs in drug development and health monitoring may enhance drug safety in the future, according to an editorial to be published in the next edition of the British Journal of Clinical Pharmacology.

21 Sep 2015

Former soldier Trevor Greene walks again with the help of exoskeleton at SFU's Surrey campus

Former Canadian soldier Trevor Greene, who survived a debilitating brain injury while on duty in Afghanistan in 2006, has recovered his ability to walk again with the help of a customized exoskeleton, his personal determination and support of researchers at Simon Fraser University.

21 Sep 2015

Patient-oriented approach becomes a formula for long-term success in pharmaceutical industry

In the evolving global healthcare marketplace, a patient-centric approach has become part of the formula for long-term success in the pharmaceutical sector. Facing declining sales from patent losses and payer pressures, the pharma sector is turning to patient support programs and activities to help drive clinical and commercial success.

19 Sep 2015

Healthcare News and Research

Latest Healthcare News and Research

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

Medgen completes acquisition of Alternaturals

Stanford Hospital starts key study on pressure ulcer prevention

Bisphosphonate drugs linked to greater risk of atypical hip fractures

FDA approves Impax Laboratories' generic version of Testred Capsules 10 mg

UIC to develop and test outreach program to improve children’s oral health in Chicago

AmpliPhi's novel bacteriophage therapy demonstrates comparable efficacy to vancomycin in S. aureus lung infection model

Survey: Only half of primary care physicians aware of Complete Emollient Therapy for managing patients with eczema

New Medicare payment model reduces use of low-value services

New study calls for new treatments for carbapenem-resistant Enterobacteriaceae infection

BWH, DFCI researchers receive $10 million to test effectiveness of aspirin in women with breast cancer

Study compares effectiveness of nafcillin and cefazolin in patients with MSSA blood stream infections

Prime Healthcare Services agrees to acquire Lehigh Regional Medical Center

PDL BioPharma purchases portion of royalties on expected sales of AcelRx's Zalviso

Mölnlycke Health Care selects Mindtree to improve SAP application management

Invitae launches new education program to increase awareness of genetic testing for hereditary cancer

Evidera releases new software platform to support real-time analysis of healthcare data

Promising new innovations in drug development, health monitoring may improve drug safety in the future

Former soldier Trevor Greene walks again with the help of exoskeleton at SFU's Surrey campus

Patient-oriented approach becomes a formula for long-term success in pharmaceutical industry

Event guide: 3rd Measuring Patient Engagement Summit eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Healthcare News and Research

Latest Healthcare News and Research

Event guide: 3rd Measuring Patient Engagement Summit eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in